<DOC>
	<DOCNO>NCT00667589</DOCNO>
	<brief_summary>The purpose study evaluate treatment rash cause sorafenib .</brief_summary>
	<brief_title>Sorafenib-induced Hand- Foot Skin Reaction Treatment</brief_title>
	<detailed_description>This study compare compare effectiveness four cream ( urea 40 % cream , fluocinonide 0.05 % cream , tazarotene 0.1 % cream , Udderly smoothÂ® Udder Cream ) treat hand-foot skin reaction ( HFSR ) , rash cause sorafenib .</detailed_description>
	<mesh_term>Sorafenib</mesh_term>
	<mesh_term>Fluocinonide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<mesh_term>Tazarotene</mesh_term>
	<mesh_term>Emollients</mesh_term>
	<criteria>Patients receive sorafenib monotherapy combination agent know cause HFSR . Subjects must 18 year old . Patients must provide write informed consent participate study . Women childbearing potential men must willing use effective method contraception participate study least two week complete treatment study . Women study need negative urine pregnancy test start study medication . Patients simultaneously take another anticancer agent combination anticancer agent know cause hand foot syndrome ( pegylated doxorubicin , 5fluorouracil , cytarabine ) . Patients active dermatological condition due previous chemotherapy biologic therapy affect hand . Patients preexist dermatological condition affect hand foot . Women positive pregnancy test lactating .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>sorafenib</keyword>
	<keyword>rash</keyword>
	<keyword>hand foot skin reaction</keyword>
</DOC>